198 related articles for article (PubMed ID: 33527209)
1. Effectiveness of ketogenic diet in treatment of patients with refractory chronic migraine.
Bongiovanni D; Benedetto C; Corvisieri S; Del Favero C; Orlandi F; Allais G; Sinigaglia S; Fadda M
Neurol Sci; 2021 Sep; 42(9):3865-3870. PubMed ID: 33527209
[TBL] [Abstract][Full Text] [Related]
2. Ketogenic diet in refractory migraine: possible efficacy and role of ketone bodies-a pilot experience.
Lovati C; d'Alessandro CM; Ventura SD; Muzio F; Pantoni L
Neurol Sci; 2022 Nov; 43(11):6479-6485. PubMed ID: 35948778
[TBL] [Abstract][Full Text] [Related]
3. Chronic migraine: current concepts and ongoing treatments.
Negro A; Rocchietti-March M; Fiorillo M; Martelletti P
Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1401-20. PubMed ID: 22288302
[TBL] [Abstract][Full Text] [Related]
4. Migraine improvement during short lasting ketogenesis: a proof-of-concept study.
Di Lorenzo C; Coppola G; Sirianni G; Di Lorenzo G; Bracaglia M; Di Lenola D; Siracusano A; Rossi P; Pierelli F
Eur J Neurol; 2015 Jan; 22(1):170-7. PubMed ID: 25156013
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Three Different Ketogenic Diet Protocols on Migraine and Fatigue in Chronic and High-Frequency Episodic Migraine: A Pilot Study.
Tereshko Y; Dal Bello S; Di Lorenzo C; Pittino A; Filippi F; Belgrado E; Lettieri C; Merlino G; Gigli GL; Valente M
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892410
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
[TBL] [Abstract][Full Text] [Related]
7. Sleep of migraine patients is ameliorated by ketogenic diet, independently of pain control.
Merlino G; Tereshko Y; Pez S; Dal Bello S; Pittino A; Di Lorenzo C; Filippi F; Lettieri C; Belgrado E; Gigli GL; Valente M
Sleep Med; 2023 Jul; 107():196-201. PubMed ID: 37209426
[TBL] [Abstract][Full Text] [Related]
8. Ketogenic diet in migraine: rationale, findings and perspectives.
Barbanti P; Fofi L; Aurilia C; Egeo G; Caprio M
Neurol Sci; 2017 May; 38(Suppl 1):111-115. PubMed ID: 28527061
[TBL] [Abstract][Full Text] [Related]
9. Medication overuse and chronic migraine: a critical review according to clinical pharmacology.
Ferrari A; Baraldi C; Sternieri E
Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1127-44. PubMed ID: 26027878
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Double-Blind, Cross-Over Trial of very Low-Calorie Diet in Overweight Migraine Patients: A Possible Role for Ketones?
Di Lorenzo C; Pinto A; Ienca R; Coppola G; Sirianni G; Di Lorenzo G; Parisi V; Serrao M; Spagnoli A; Vestri A; Schoenen J; Donini LM; Pierelli F
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31357685
[TBL] [Abstract][Full Text] [Related]
11. Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trial.
Engelstoft IMS; Carlsen LN; Munksgaard SB; Nielsen M; Jensen RH; Bendtsen L
Eur J Pain; 2019 Jul; 23(6):1162-1170. PubMed ID: 30793412
[TBL] [Abstract][Full Text] [Related]
12. Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria.
Zeeberg P; Olesen J; Jensen R
Cephalalgia; 2009 Feb; 29(2):214-20. PubMed ID: 18823364
[TBL] [Abstract][Full Text] [Related]
13. Predictors of First-Line Treatment Success in Children and Adolescents Visiting an Infusion Center for Acute Migraine.
Orr SL; Kabbouche MA; Horn PS; O'Brien HL; Kacperski J; LeCates S; White S; Weberding J; Miller MN; Powers SW; Hershey AD
Headache; 2018 Sep; 58(8):1194-1202. PubMed ID: 29926909
[TBL] [Abstract][Full Text] [Related]
14. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
15. [Botulinum toxin A in chronic refractory migraine: premarketing experience].
Álvaro-González LC; Fernández-García JM; Aranzábal-Alustiza I; Castillo-Calvo B; Iriondo-Etxenagusia I; Rodríguez-Antigüedad A
Rev Neurol; 2012 Oct; 55(7):385-91. PubMed ID: 23011856
[TBL] [Abstract][Full Text] [Related]
16. 2:1 ketogenic diet and low-glycemic-index diet for the treatment of chronic and episodic migraine: a single-center real-life retrospective study.
Tereshko Y; Dal Bello S; Di Lorenzo C; Pez S; Pittino A; Sartor R; Filippi F; Lettieri C; Belgrado E; Garbo R; Merlino G; Gigli GL; Valente M
J Headache Pain; 2023 Jul; 24(1):95. PubMed ID: 37501109
[TBL] [Abstract][Full Text] [Related]
17. A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.
Negro A; Curto M; Lionetto L; Martelletti P
J Headache Pain; 2015; 17():1. PubMed ID: 26792662
[TBL] [Abstract][Full Text] [Related]
18. Clinical considerations on chronic migraine, pharmacoresistance and refractoriness.
Bussone G
Neurol Sci; 2010 Jun; 31 Suppl 1():S83-5. PubMed ID: 20464591
[TBL] [Abstract][Full Text] [Related]
19. Probable medication-overuse headache: the effect of a 2-month drug-free period.
Zeeberg P; Olesen J; Jensen R
Neurology; 2006 Jun; 66(12):1894-8. PubMed ID: 16707727
[TBL] [Abstract][Full Text] [Related]
20. The role of personality, disability and physical activity in the development of medication-overuse headache: a prospective observational study.
Mose LS; Pedersen SS; Debrabant B; Jensen RH; Gram B
J Headache Pain; 2018 May; 19(1):39. PubMed ID: 29802536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
